Austin Health

Title
Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.
Publication Date
2017
Author(s)
Frost, Shaun
Robinson, Liam
Rowe, Christopher C
Ames, David
Masters, Colin L
Taddei, Kevin
Rainey-Smith, Stephanie R
Martins, Ralph N
Kanagasingam, Yogesan
Type of document
Journal Article
OrcId
0000-0002-1681-8224
0000-0003-3910-2453
DOI
10.1155/2017/7935406
Abstract
Cortical cholinergic deficiency is prominent in Alzheimer's disease (AD), and published findings of diminished pupil flash response in AD suggest that this deficiency may extend to the visual cortical areas and anterior eye. Pupillometry is a low-cost, noninvasive technique that may be useful for monitoring cholinergic deficits which generally lead to memory and cognitive disorders. The aim of the study was to evaluate pupillometry for early detection of AD by comparing the pupil flash response (PFR) in AD (N = 14) and cognitively normal healthy control (HC, N = 115) participants, with the HC group stratified according to high (N = 38) and low (N = 77) neocortical amyloid burden (NAB). Constriction phase PFR parameters were significantly reduced in AD compared to HC (maximum acceleration p < 0.05, maximum velocity p < 0.0005, average velocity p < 0.005, and constriction amplitude p < 0.00005). The high-NAB HC subgroup had reduced PFR response cross-sectionally, and also a greater decline longitudinally, compared to the low-NAB subgroup, suggesting changes to pupil response in preclinical AD. The results suggest that PFR changes may occur in the preclinical phase of AD. Hence, pupillometry has a potential as an adjunct for noninvasive, cost-effective screening for preclinical AD.
Link
Citation
Journal of ophthalmology 2017; 2017: 7935406
Jornal Title
Journal of ophthalmology
ISSN
2090-004X

Files:

NameSizeformatDescriptionLink